WASHINGTON — Vice President Mike Pence publicly threw his support behind efforts to help terminally ill patients access experimental treatments in a Thursday morning tweet. “Let’s get this DONE,” Pence said about the “right-to-try” legislation currently stalled in Congress, citing a meeting earlier this week with Food and Drug Administration Commissioner Scott Gottlieb.

Pence, a longtime advocate of right-to-try legislation, has been working with his staff and several lawmakers who support the measures to pressure leaders in the House of Representatives to act on the issue early this year, several members have confirmed to STAT. The Senate passed legislation, from Sens. Ron Johnson (R-Wis.) and Joe Donnelly (D-Ind.), last fall.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy